Weekly infusion trial offers new hope for Hard-to-Treat esophagus condition
NCT ID NCT05485155
Summary
This study is testing whether a medication called Zemaira, given as a weekly infusion for four weeks, can help adults with eosinophilic esophagitis. Researchers want to see if the treatment reduces inflammation in the esophagus and improves symptoms. The study will also monitor for any side effects from the treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EOSINOPHILIC ESOPHAGITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45229, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The National Institutes of Health
RECRUITINGBethesda, Maryland, 20892, United States
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.